US Stock MarketDetailed Quotes

ZTS Zoetis

Watchlist
  • 158.420
  • +5.060+3.30%
Close Apr 26 16:00 ET
  • 158.860
  • +0.440+0.28%
Post 19:56 ET
72.39BMarket Cap31.25P/E (TTM)

About Zoetis Company

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

Company Profile

SymbolZTS
Company NameZoetis
Listing DateFeb 1, 2013
Issue Price26.00
Founded1952
CEOMs. Kristin C. Peck
MarketNYSE
Employees14100
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address10 Sylvan Way
CityParsippany
ProvinceNew Jersey
CountryUnited States of America
Zip Code07054
Phone1-973-822-7000

Company Executives

  • Name
  • Position
  • Salary
  • Kristin C. Peck
  • Director and Chief Executive Officer
  • 15.24M
  • Roxanne Lagano
  • Chief Human Resources Officer, Executive Vice President, Global Operations and Interim General Counsel and Corporate Secretary
  • --
  • Jeannette Ferran Astorga
  • Executive Vice President, Corporate Affairs, Communications and Chief Sustainability Officer
  • --
  • Wafaa Mamilli
  • Executive Vice President, Chief Digital Officer and Chief Technology Officer and Group President ,China, Brazil and Precision Animal Health
  • 2.69M
  • Wetteny Joseph
  • Executive Vice President, Principal Accounting Officer and Chief Financial Officer
  • 4.25M
  • Ester Soria Banque
  • Executive Vice President and President, U.S. Operations
  • --
  • Nick Ashton
  • Executive Vice President and President, Global Manufacturing and Supply
  • --
  • Rimma Driscoll
  • Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
  • --
  • Jamie Brannan
  • Executive Vice President and Group President, International Operations, Aquaculture and Global Diagnostics
  • --
  • Dr. Robert J. Polzer, PhD
  • Executive Vice President and President, Research and Development
  • 2.44M
  • Michael B. McCallister
  • Non-Executive Chairman of the Board
  • 490.00K
  • Gavin D.K. Hattersley
  • Director
  • --
  • Frank A. D'Amelio
  • Independent Director
  • 340.50K
  • Vanessa Broadhurst
  • Independent Director
  • 341.00K
  • Gregory Norden
  • Independent Director
  • 365.00K
  • Sanjay Khosla
  • Independent Director
  • 340.00K
  • Dr. Linda Rhodes,PhD
  • Independent Director
  • 345.00K
  • Robert W. Scully
  • Independent Director
  • 365.00K
  • Antoinette R. Leatherberry
  • Independent Director
  • 340.00K
  • Louise M. Parent
  • Independent Director
  • 370.00K
  • Paul M. Bisaro
  • Independent Director
  • 340.00K
  • Dr. Willie M. Reed
  • Independent Director
  • 370.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg